Norges Bank’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-566,881
| Closed | -$48.2M | – | 2119 |
|
|
2019
Q4 | $48.2M | Buy |
566,881
+19,228
| +4% | +$1.28M | 0.01% | 942 |
|
|
2019
Q3 | $27.4M | Sell |
547,653
-27,027
| -5% | -$1.08M | 0.01% | 1275 |
|
|
2019
Q2 | $21M | Buy |
574,680
+145,398
| +34% | +$4.75M | 0.01% | 1474 |
|
|
2019
Q1 | $12M | Buy |
429,282
+35,893
| +9% | +$846K | ﹤0.01% | 1745 |
|
|
2018
Q4 | $7.53M | Buy |
393,389
+36,088
| +10% | +$839K | ﹤0.01% | 1827 |
|
|
2018
Q3 | $10.7M | Hold |
357,301
| – | – | ﹤0.01% | 1804 |
|
|
2018
Q2 | $13.1M | Hold |
357,301
| – | – | ﹤0.01% | 1728 |
|
|
2018
Q1 | $11.8M | Sell |
357,301
-158,176
| -31% | -$4.94M | ﹤0.01% | 1690 |
|
|
2017
Q4 | $14.1M | Hold |
515,477
| – | – | 0.01% | 1612 |
|
|
2017
Q3 | $19.1M | Buy |
515,477
+37,227
| +8% | +$1.37M | 0.01% | 1476 |
|
|
2017
Q2 | $18.2M | Hold |
478,250
| – | – | 0.01% | 1477 |
|
|
2017
Q1 | $23.4M | Sell |
478,250
-187,596
| -28% | -$8.56M | 0.01% | 1286 |
|
|
2016
Q4 | $22.6M | Hold |
665,846
| – | – | 0.01% | 1231 |
|
|
2016
Q3 | $24M | Buy |
665,846
+93,102
| +16% | +$3.51M | 0.01% | 1098 |
|
|
2016
Q2 | $19.3M | Hold |
572,744
| – | – | 0.01% | 1221 |
|
|
2016
Q1 | $18.2M | Hold |
572,744
| – | – | 0.01% | 1210 |
|
|
2015
Q4 | $21.4M | Buy |
572,744
+228,560
| +66% | +$8.64M | 0.01% | 1129 |
|
|
2015
Q3 | $13.1M | Sell |
344,184
-28,398
| -8% | -$997K | 0.01% | 1400 |
|
|
2015
Q2 | $10.7M | Sell |
372,582
-115,828
| -24% | -$3.23M | 0.01% | 1587 |
|
|
2015
Q1 | $13.7M | Sell |
488,410
-49,643
| -9% | -$1.39M | 0.01% | 1464 |
|
|
2014
Q4 | $14.9M | Buy |
538,053
+128,535
| +31% | +$3.18M | 0.01% | 1409 |
|
|
2014
Q3 | $9.14M | Sell |
409,518
-409,518
| -50% | -$10.4M | 0.01% | 1646 |
|
|
2014
Q2 | $23.8M | Buy |
819,036
+433,451
| +112% | +$11.6M | 0.01% | 1531 |
|
|
2014
Q1 | $11M | Sell |
385,585
-7,565
| -2% | -$250K | 0.01% | 1531 |
|
|
2013
Q4 | $15.2M | Hold |
393,150
| – | – | 0.01% | 1319 |
|
|
2013
Q3 | $13.2M | Buy |
393,150
+162,502
| +70% | +$5.18M | 0.01% | 1383 |
|
|
2013
Q2 | $7.09M | Buy |
+230,648
| New | +$7.72M | ﹤0.01% | 1678 |
|
Other funds holding MDCO
Norges Bank's MDCO Position: Q1 2020 in Review
Norges Bank sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 566,881 shares — an estimated $48.2M sold.
Norges Bank first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $48.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Norges Bank reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Norges Bank sold 566,881 Medicines Co shares in Q1 2020, an estimated $48.2M.
- Norges Bank first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Norges Bank's Medicines Co position peaked at $48.2M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Norges Bank's 13F filing for Q1 2020, filed 8 May 2020.